Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum

A number of COVID-19 vaccines have been approved worldwide to help tackle the pandemic. As with many vaccines, this causes a reactive axillary lymphadenopathy which can mimic potentially metastatic disease in a breast screening patient. It is therefore important to be aware of this side-effect of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Musaddaq, Besma, Brown, Adam, Dluzewski, Sam, Marafioti, Teresa, Malhotra, Anmol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906153/
https://www.ncbi.nlm.nih.gov/pubmed/35300233
http://dx.doi.org/10.1259/bjrcr.20210063
_version_ 1784665347569221632
author Musaddaq, Besma
Brown, Adam
Dluzewski, Sam
Marafioti, Teresa
Malhotra, Anmol
author_facet Musaddaq, Besma
Brown, Adam
Dluzewski, Sam
Marafioti, Teresa
Malhotra, Anmol
author_sort Musaddaq, Besma
collection PubMed
description A number of COVID-19 vaccines have been approved worldwide to help tackle the pandemic. As with many vaccines, this causes a reactive axillary lymphadenopathy which can mimic potentially metastatic disease in a breast screening patient. It is therefore important to be aware of this side-effect of the vaccination when evaluating the axilla in a breast screening patient. We present a case of biopsy-proven unilateral reactive axillary lymphadenopathy in a high risk BRCA carrier following administration of the Astra Zeneca vaccine.
format Online
Article
Text
id pubmed-8906153
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Institute of Radiology.
record_format MEDLINE/PubMed
spelling pubmed-89061532022-03-16 Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum Musaddaq, Besma Brown, Adam Dluzewski, Sam Marafioti, Teresa Malhotra, Anmol BJR Case Rep Case Report A number of COVID-19 vaccines have been approved worldwide to help tackle the pandemic. As with many vaccines, this causes a reactive axillary lymphadenopathy which can mimic potentially metastatic disease in a breast screening patient. It is therefore important to be aware of this side-effect of the vaccination when evaluating the axilla in a breast screening patient. We present a case of biopsy-proven unilateral reactive axillary lymphadenopathy in a high risk BRCA carrier following administration of the Astra Zeneca vaccine. The British Institute of Radiology. 2022-03-09 /pmc/articles/PMC8906153/ /pubmed/35300233 http://dx.doi.org/10.1259/bjrcr.20210063 Text en © 2021 The Authors. Published by the British Institute of Radiology https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
spellingShingle Case Report
Musaddaq, Besma
Brown, Adam
Dluzewski, Sam
Marafioti, Teresa
Malhotra, Anmol
Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum
title Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum
title_full Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum
title_fullStr Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum
title_full_unstemmed Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum
title_short Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum
title_sort axillary lymphadenopathy in a high-risk breast screening patient following the covid-19 vaccine: a diagnostic conundrum
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906153/
https://www.ncbi.nlm.nih.gov/pubmed/35300233
http://dx.doi.org/10.1259/bjrcr.20210063
work_keys_str_mv AT musaddaqbesma axillarylymphadenopathyinahighriskbreastscreeningpatientfollowingthecovid19vaccineadiagnosticconundrum
AT brownadam axillarylymphadenopathyinahighriskbreastscreeningpatientfollowingthecovid19vaccineadiagnosticconundrum
AT dluzewskisam axillarylymphadenopathyinahighriskbreastscreeningpatientfollowingthecovid19vaccineadiagnosticconundrum
AT marafiotiteresa axillarylymphadenopathyinahighriskbreastscreeningpatientfollowingthecovid19vaccineadiagnosticconundrum
AT malhotraanmol axillarylymphadenopathyinahighriskbreastscreeningpatientfollowingthecovid19vaccineadiagnosticconundrum

Ejemplares similares